Literature DB >> 27402833

Structure and Glycan Binding of a New Cyanovirin-N Homolog.

Elena Matei1, Rohan Basu2, William Furey3, Jiong Shi4, Conor Calnan5, Christopher Aiken4, Angela M Gronenborn6.   

Abstract

The HIV-1 envelope glycoprotein gp120 is heavily glycosylated and bears numerous high mannose sugars. These sugars can serve as targets for HIV-inactivating compounds, such as antibodies and lectins, which bind to the glycans and interfere with viral entry into the target cell. We determined the 1.6 Å x-ray structure of Cyt-CVNH, a recently identified lectin from the cyanobacterium Cyanothece(7424), and elucidated its glycan specificity by NMR. The Cyt-CVNH structure and glycan recognition profile are similar to those of other CVNH proteins, with each domain specifically binding to Manα(1-2)Manα units on the D1 and D3 arms of high mannose glycans. However, in contrast to CV-N, no cross-linking and precipitation of the cross-linked species in solution was observed upon Man-9 binding, allowing, for the first time, investigation of the interaction of Man-9 with a member of the CVNH family by NMR. HIV assays showed that Cyt-CVNH is able to inhibit HIV-1 with ∼4-fold higher potency than CV-N(P51G), a stabilized version of wild type CV-N. Therefore, Cyt-CVNH may qualify as a valuable lectin for potential microbicidal use.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  X-ray crystallography; antiviral agent; human immunodeficiency virus (HIV); lectin; nuclear magnetic resonance (NMR); oligosaccharide

Mesh:

Substances:

Year:  2016        PMID: 27402833      PMCID: PMC5009269          DOI: 10.1074/jbc.M116.740415

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.

Authors:  Laura G Barrientos; John M Louis; Istvan Botos; Toshiyuki Mori; Zhaozhong Han; Barry R O'Keefe; Michael R Boyd; Alexander Wlodawer; Angela M Gronenborn
Journal:  Structure       Date:  2002-05       Impact factor: 5.006

2.  Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.

Authors:  F Yang; C A Bewley; J M Louis; K R Gustafson; M R Boyd; A M Gronenborn; G M Clore; A Wlodawer
Journal:  J Mol Biol       Date:  1999-05-07       Impact factor: 5.469

3.  Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization.

Authors:  Shilpa R Shenoy; Laura G Barrientos; Daniel M Ratner; Barry R O'Keefe; Peter H Seeberger; Angela M Gronenborn; Michael R Boyd
Journal:  Chem Biol       Date:  2002-10

4.  Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner.

Authors:  A J Bolmstedt; B R O'Keefe; S R Shenoy; J B McMahon; M R Boyd
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

5.  Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.

Authors:  S R Shenoy; B R O'Keefe; A J Bolmstedt; L K Cartner; M R Boyd
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

6.  The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.

Authors:  C A Bewley; S Otero-Quintero
Journal:  J Am Chem Soc       Date:  2001-05-02       Impact factor: 15.419

7.  The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Authors:  Christopher N Scanlan; Ralph Pantophlet; Mark R Wormald; Erica Ollmann Saphire; Robyn Stanfield; Ian A Wilson; Hermann Katinger; Raymond A Dwek; Pauline M Rudd; Dennis R Burton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

Authors:  Rogier W Sanders; Miro Venturi; Linnea Schiffner; Roopa Kalyanaraman; Hermann Katinger; Kenneth O Lloyd; Peter D Kwong; John P Moore
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.

Authors:  Istvan Botos; Barry R O'Keefe; Shilpa R Shenoy; Laura K Cartner; Daniel M Ratner; Peter H Seeberger; Michael R Boyd; Alexander Wlodawer
Journal:  J Biol Chem       Date:  2002-07-10       Impact factor: 5.157

10.  Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.

Authors:  Daniel A Calarese; Christopher N Scanlan; Michael B Zwick; Songpon Deechongkit; Yusuke Mimura; Renate Kunert; Ping Zhu; Mark R Wormald; Robyn L Stanfield; Kenneth H Roux; Jeffery W Kelly; Pauline M Rudd; Raymond A Dwek; Hermann Katinger; Dennis R Burton; Ian A Wilson
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

View more
  6 in total

1.  Interactions between tetrahydroisoindoline-1,3-dione derivatives and human serum albumin via multiple spectroscopy techniques.

Authors:  Meiqing Zhu; Lijun Wang; Hao Zhang; Shisuo Fan; Zhen Wang; Qing X Li; Yi Wang; Shangzhong Liu
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-18       Impact factor: 4.223

2.  Functionalized High Mannose-Specific Lectins for the Discovery of Type I Mannosidase Inhibitors.

Authors:  Suresh E Kurhade; Jack D Weiner; Fei Philip Gao; Mark P Farrell
Journal:  Angew Chem Int Ed Engl       Date:  2021-04-26       Impact factor: 16.823

Review 3.  An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

Authors:  Hajie Lotfi; Roghayeh Sheervalilou; Nosratollah Zarghami
Journal:  Bioimpacts       Date:  2017-11-16

Review 4.  Antiviral Potential of Algal Metabolites-A Comprehensive Review.

Authors:  António Pagarete; Ana Sofia Ramos; Pål Puntervoll; Michael J Allen; Vítor Verdelho
Journal:  Mar Drugs       Date:  2021-02-06       Impact factor: 5.118

Review 5.  Antiviral Cyanometabolites-A Review.

Authors:  Hanna Mazur-Marzec; Marta Cegłowska; Robert Konkel; Krzysztof Pyrć
Journal:  Biomolecules       Date:  2021-03-22

6.  Genomic screening of new putative antiviral lectins from Amazonian cyanobacteria based on a bioinformatics approach.

Authors:  Andrei Santos Siqueira; Alex Ranieri Jerônimo Lima; Delia Cristina Figueira Aguiar; Alberdan Silva Santos; João Lídio da Silva Gonçalves Vianez Júnior; Evonnildo Costa Gonçalves
Journal:  Proteins       Date:  2018-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.